Table 2.
Outcomes measures at the baseline, the end of the MBSR program (3 months) (V1), and the final follow-up (6 months) (V2)
| MBSR group | Usual care group | P value | |
|---|---|---|---|
| Primary Outcome (mean (SD)) | |||
| WOMAC pain | |||
| Baseline | 55.6 (16.7) (n = 20) | 47.9 (14.8) (n = 20) | 0.15 |
| V1 | 47.2 (17.6) (n = 18) | 36.7 (25.7) (n = 12) | 0.19 |
| V2 | 38.0 (19.8) (n = 20) | 39.7 (20.3) (n = 15) | 0.80 |
| Secondary Outcomes (mean (SD)) | |||
| WOMAC function | |||
| Baseline | 49.0 (19.2) (n = 20) | 45.5 (14.4) (n = 20) | 0.54 |
| V1 | 43.3 (17.0) (n = 13) | 36.4 (24.3) (n = 13) | 0.41 |
| V2 | 38.5 (19.6) (n = 18) | 39.7 (22.0) (n = 14) | 0.86 |
| WOMAC stiffness | |||
| Baseline | 59.4 (17.6) (n = 20) | 52.2 (22.1) (n = 20) | 0.28 |
| V1 | 55.3 (23.7) (n = 19) | 48.3 (19.4) (n = 15) | 0.36 |
| V2 | 40.6 (16.7) (n = 20) | 48.4 (25.8) (n = 16) | 0.27 |
| WOMAC total | |||
| Baseline | 55.1 (13.6) (n = 20) | 48.6 (14.8) (n = 20) | 0.20 |
| V1 | 46.4 (16.6) (n = 12) | 38.4 (22.5) (n = 11) | 0.34 |
| V2 | 40.7 (16.5) (n = 18) | 43.7 (22.4) (n = 14) | 0.67 |
| VAS pain | |||
| Baseline | 64.0 (12.2) (n = 20) | 60.0 (12.7) (n = 20) | 0.30 |
| V1 | 41.4 (25.3) (n = 20) | 44.8 (26.5) (n = 16) | 0.70 |
| V2 | 34.4 (27.2) (n = 20) | 48.7 (26.9) (n = 16) | 0.12 |
| SF36 physical score | |||
| Baseline | 34.8 (8.1) (n = 20) | 36.1 (8.2) (n = 18) | 0.62 |
| V1 | 36.6 (7.9) (n = 20) | 39.5 (9.5) (n = 15) | 0.33 |
| V2 | 38.6 (10.5) (n = 20) | 40.1 (11.8) (n = 15) | 0.68 |
| SF36 mental score | |||
| Baseline | 48.1 (9.6) (n = 20) | 42.4 (12.0) (n = 20) | 0.11 |
| V1 | 50.7 (7.9) (n = 20) | 41.8 (11.4) (n = 15) | 0.01* |
| V2 | 50.0 (8.6) (n = 20) | 41.3 (14.3) (n = 15) | 0.11 |
| HAD anxiety | |||
| Baseline | 7.3 (4.0) (n = 20) | 8.4 (4.3) (n = 20) | 0.40 |
| V1 | 5.2 (3.4) (n = 20) | 8.4 (4.3) (n = 15) | 0.08 |
| V2 | 6.2 (4.4) (n = 20) | 7.5 (4.7) (n = 16) | 0.08 |
| HAD depression | |||
| Baseline | 4.1 (3.3) (n = 20) | 5.3 (3.6) (n = 20) | 0.28 |
| V1 | 3.4 (2.2) (n = 20) | 4.8 (3.5) (n = 15) | 0.14 |
| V2 | 3.5 (2.9) (n = 20) | 5.1 (3.9) (n = 16) | 0.21 |
| FFMQ observation factor | |||
| Baseline | 29.3 (5.5) (n = 19) | 26.9 (5.9) (n = 20) | 0.20 |
| V1 | 31.9 (4.2) (n = 20) | 26.9 (5.9) (n = 16) | 0.03* |
| V2 | 32.1 (4.5) (n = 20) | 26.6 (5.8) (n = 16) | 0.01* |
| FFMQ description experience factor | |||
| Baseline | 29.0 (5.4) (n = 19) | 28.3 (6.8) (n = 19) | 0.74 |
| V1 | 30.1 (4.7) (n = 20) | 29.7 (7.4) (n = 15) | 0.87 |
| V2 | 31.1 (4.7) (n = 20) | 30.0 (8.2) (n = 16) | 0.83 |
| FFMQ mindfulness factor | |||
| Baseline | 28.6 (6.3) (n = 19) | 27.8 (5.7) (n = 19) | 0.70 |
| V1 | 29.0 (6.5) (n = 19) | 28.1 (6.9) (n = 16) | 0.71 |
| V2 | 30.1 (6.6) (n = 20) | 29.4 (6.8) (n = 15) | 0.76 |
| FFMQ private event factor | |||
| Baseline | 18.8 (5.0) (n = 19) | 21.2 (3.9) (n = 20) | 0.11 |
| V1 | 23.8 (5.7) (n = 19) | 19.6 (4.1) (n = 15) | 0.02* |
| V2 | 23.1 (5.2) (n = 20) | 21.2 (4.3) (n = 16) | 0.25 |
| FFMQ no judgment factor | |||
| Baseline | 28.0 (5.8) (n = 20) | 26.3 (7.4) (n = 20) | 0.41 |
| V1 | 28.2 (6.2) (n = 19) | 28.5 (6.6) (n = 15) | 0.86 |
| V2 | 30.7 (6.4) (n = 20) | 27.1 (7.5) (n = 16) | 0.13 |
| FFMQ total mindfulness | |||
| Baseline | 133.2 (17.0) (n = 18) | 131.1 (21.8) (n = 18) | 0.74 |
| V1 | 145.0 (20.0) (n = 18) | 131.5 (25.0) (n = 13) | 0.10 |
| V2 | 147.0 (17.3) (n = 20) | 133.7 (26.4) (n = 15) | 0.08 |
VAS visual analogic scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, SF-36 36-Item Short-Form Health Survey, FFMQ Five Facets Mindfulness Questionnaire, HAD hospital anxiety and depression
*Significant difference between groups